Glenmede Trust’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224K | Buy |
10,189
+6
| +0.1% | +$104 | ﹤0.01% | 1260 |
|
|
2025
Q4 | $120K | Buy |
+10,183
| New | +$131K | ﹤0.01% | 1330 |
|
|
2025
Q1 | $139K | Buy |
+10,250
| New | +$170K | ﹤0.01% | 1247 |
|
|
2024
Q1 | – | Sell |
-7,650
| Closed | -$241K | – | 1350 |
|
|
2023
Q4 | $241K | Sell |
7,650
-247
| -3% | -$6.7K | ﹤0.01% | 1095 |
|
|
2023
Q3 | $222K | Buy |
7,897
+178
| +2% | +$6.11K | ﹤0.01% | 1076 |
|
|
2023
Q2 | $231K | Hold |
7,719
| – | – | ﹤0.01% | 1062 |
|
|
2023
Q1 | $231K | Sell |
7,719
-963
| -11% | -$31.7K | ﹤0.01% | 1067 |
|
|
2022
Q4 | $266K | Buy |
8,682
+384
| +5% | +$11.5K | ﹤0.01% | 1020 |
|
|
2022
Q3 | $204K | Buy |
8,298
+818
| +11% | +$27K | ﹤0.01% | 1086 |
|
|
2022
Q2 | $239K | Sell |
7,480
-380
| -5% | -$14K | ﹤0.01% | 1056 |
|
|
2022
Q1 | $246K | Buy |
7,860
+44
| +0.6% | +$1.38K | ﹤0.01% | 1086 |
|
|
2021
Q4 | $261K | Sell |
7,816
-22
| -0.3% | -$685 | ﹤0.01% | 1085 |
|
|
2021
Q3 | $227K | Sell |
7,838
-272
| -3% | -$8.8K | ﹤0.01% | 1103 |
|
|
2021
Q2 | $281K | Sell |
8,110
-67
| -0.8% | -$2.22K | ﹤0.01% | 1049 |
|
|
2021
Q1 | $227K | Sell |
8,177
-100
| -1% | -$2.66K | ﹤0.01% | 1043 |
|
|
2020
Q4 | $204K | Sell |
8,277
-15,000
| -64% | -$357K | ﹤0.01% | 1055 |
|
|
2020
Q3 | $486K | Buy |
23,277
+14,840
| +176% | +$286K | ﹤0.01% | 788 |
|
|
2020
Q2 | $128K | Sell |
8,437
-5,807
| -41% | -$73.4K | ﹤0.01% | 1104 |
|
|
2020
Q1 | $256K | Hold |
14,244
| – | – | ﹤0.01% | 1100 |
|
|
2019
Q4 | $256K | Sell |
14,244
-992
| -7% | -$16.5K | ﹤0.01% | 1100 |
|
|
2019
Q3 | $226 | Sell |
15,236
-425
| -3% | -$6.91K | ﹤0.01% | 1117 |
|
|
2019
Q2 | $374 | Sell |
15,661
-632
| -4% | -$18.6K | ﹤0.01% | 980 |
|
|
2019
Q1 | $604 | Buy |
16,293
+300
| +2% | +$10.9K | ﹤0.01% | 843 |
|
|
2018
Q4 | $450 | Buy |
15,993
+131
| +0.8% | +$4.14K | ﹤0.01% | 882 |
|
|
2018
Q3 | $625K | Sell |
15,862
-6,344
| -29% | -$278K | ﹤0.01% | 850 |
|
|
2018
Q2 | $985K | Buy |
22,206
+564
| +3% | +$28.1K | ﹤0.01% | 709 |
|
|
2018
Q1 | $1.08M | Hold |
21,642
| – | – | ﹤0.01% | 766 |
|
|
2017
Q4 | $1.08M | Sell |
21,642
-764
| -3% | -$40K | ﹤0.01% | 766 |
|
|
2017
Q3 | $1.13M | Sell |
22,406
-10,610
| -32% | -$501K | 0.01% | 739 |
|
|
2017
Q2 | $1.27M | Hold |
33,016
| – | – | 0.01% | 729 |
|
|
2017
Q1 | $1.27M | Buy |
33,016
+8,278
| +33% | +$249K | 0.01% | 729 |
|
|
2016
Q4 | $546K | Sell |
24,738
-72,724
| -75% | -$1.49M | ﹤0.01% | 920 |
|
|
2016
Q3 | $1.56M | Sell |
97,462
-2,158
| -2% | -$24.6K | 0.01% | 672 |
|
|
2016
Q2 | $820K | Sell |
99,620
-48,000
| -33% | -$428K | 0.01% | 793 |
|
|
2016
Q1 | $1.03M | Sell |
147,620
-12,664
| -8% | -$63.6K | 0.01% | 738 |
|
|
2015
Q4 | $858K | Sell |
160,284
-32,298
| -17% | -$206K | 0.01% | 786 |
|
|
2015
Q3 | $1.25M | Buy |
+192,582
| New | +$2.02M | 0.01% | 692 |
|
Other funds holding CC
VPM
VCM
WHCM
Glenmede Trust's CC Position: Q1 2026 in Review
Glenmede Trust increased its Chemours (CC) stake by 0.06% in Q1 2026, buying an estimated $104 and bringing the position to 10,189 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1260.
Glenmede Trust first reported a position in CC in Q3 2015 and has held it in 37 quarters since. The position peaked at $1.56M in Q3 2016. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.
- Glenmede Trust held 10,189 shares of Chemours worth $224K as of Q1 2026.
- Glenmede Trust bought 6 Chemours shares in Q1 2026, an estimated $104.
- Chemours made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1260 holding.
- Glenmede Trust first reported a position in Chemours in Q3 2015 and has held it in 37 quarters since.
- Glenmede Trust's Chemours position peaked at $1.56M in Q3 2016.
- 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.